Skip to content
Disclosery

Royalty Pharma Sub-Manager, LLC: CYTK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Royalty Pharma Sub-Manager, LLC on CYTK, newest first. How the timeline and the estimate are built.

Royalty Pharma Sub-Manager, LLC held 980,392 CYTK shares at 2026-06-30 per its 13F-HR/A filed 2026-08-21.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F/A 980,392 shares
    Change vs previous 13F 0 shares

    34.52% of the 13F portfolio, value $83,519,594.

    13F-HR/A 0002081668-26-000018 filed by Royalty Pharma Sub-Manager, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F/A 980,392 shares
    Change vs previous 13F 0 shares

    37.4% of the 13F portfolio, value $64,617,637.

    13F-HR/A 0002081668-26-000017 filed by Royalty Pharma Sub-Manager, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F/A 980,392 shares
    Change vs previous 13F not available

    36.36% of the 13F portfolio, value $62,294,108.

    13F-HR/A 0002081668-26-000015 filed by Royalty Pharma Sub-Manager, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).